PTAB Releases September 2017 Stats
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Written By: Nathanael Luman, Ph.D. and Kerry Taylor, Ph.D.
The PTAB has released its September 2017 statistics. These statistics mark the end of the USPTO's 2017 fiscal year (the USPTO’s fiscal year runs from October 1 to September 30 of each year). A total of 1,901 IPR petitions were filed in FY2017, with the following break-down by technology area:
• 1,122 petitions (59%) were filed in the electrical/computer technology area,
• 417 petitions (22%) were filed in the mechanical and business method technology area,
• 221 petitions (11%) were filed in the bio/pharma technology area,
• 127 petitions (7%) were filed in the chemical technology area, and
• 14 petitions (1%) were filed for design patents.
The PTAB’s full statistical report can be found at (https://www.uspto.gov/sites/default/files/documents/Trial_Stats_2017-09-30.pdf).
More insights
Fresh From the Bench: Latest Precedential Patent Case
Ridge Corp. et al. v. Kirk NationaLease Co. et al. , Appeal No. 2025-1254 (Fed. Cir. July 13, 2026) In its only precedential patent opinion last week, the Federal Circuit considered an appeal of a preliminary injunction issued by the U.S. District Court…
Fresh From the Bench: Latest Precedential Patent Cases
CASE OF THE WEEK Wyeth LLC v. AstraZeneca Pharmaceuticals LP , Appeal No. 2024-2325 (Fed. Cir. July 9, 2026) In our Case of the Week, the Federal Circuit affirmed a district court ruling reversing a $107.5 million jury verdict against AstraZeneca in a case…
Enanta Pharmaceuticals, Inc. v. Pfizer Inc., Appeal No. 2025-1427 (Fed. Cir. Jun. 23, 2026)
CASE OF THE WEEK Enanta Pharmaceuticals, Inc. v. Pfizer Inc., Appeal No. 2025-1427 (Fed. Cir. Jun. 23, 2026) In our Case of the Week, the Federal Circuit affirmed summary judgment invalidating all claims of Enanta’s Patent No. 11,358,953 as…